An 8-year-old female visited our hospital because she was reportedly to have low serum ceruloplasmin levels. When she was 4 years old, she had a blood test to screen for the allergy condition at a different hospital. At that time, liver dysfunction, AST 193 IU/L (standard value, 24–38) and ALT 220 IU/L (standard value, 9–27), was pointed out. Despite the investigations, however, its cause remained unclear. She was treated with traditional Chinese medicine, but it did not decrease the serum transaminase levels. At the age of 8 years, she was introduced to our hospital for further evaluations.
KeywordsWilson disease ATP7B Copper Ceruloplasmin Kayser-Fleischer ring
- Aoki T, Suzuki M, Fujioka Y, Shimizu N, Fuji H, Nakazono H, Kawase C, Yamaguchi Y, Arashima S, Matsuda I, Arima M (1996) Neonatal and Perinatal screening, the Asian pacific perspective. In: STS L, CCP P (eds) Nationwide survey of clinical features of Wilson’s disease in Japan. The Chinese University Press, Hong Kong, pp 25–28Google Scholar
- Fujii H (1997) Ceruloplasmin and copper metabolism in presymptomatic patients with Wilson’s disease, establishment of diagnostic criteria. Biomed Res Trace Elem 8:13–21Google Scholar
- Nakamura H, Hemmi H, Shimizu N (2009) Molecular diagnosis of Wilson disease in Japanese patients. Toho J Med 56:65–70Google Scholar
- Oelshlegel FJ Jr, Brewer GJ (1997) Absorption of pharmacologic dose of zinc. Zinc metabolism: current aspects in health and disease. Alan R Liss, Inc, New York, pp p299–p316Google Scholar
- Shimizu N (2017) Molecular diagnosis for Wilson disease in Japan. Kan Tan Sui 74:169–174 (in Japanese)Google Scholar
- Shimizu N, Fujiwara J, Ohnishi S, Sato M, Kodama H, Kohsaka T, Inui A, Fujisawa T, Tamai H, Ida S, Itoh S, Ito M, Horiike N, Harada M, Yoshino M, Aoki T (2010) Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism. Transl Res 156:350–357CrossRefGoogle Scholar